ALVOW
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$0.37
+19.36%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- $136.8M
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$0.09
- EPS estimate
- -$0.05
- Revenue actual
- $106.0M
- Revenue estimate
- $103.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -2218.1%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$0.05 | -$0.09 | Miss -74.77% | $106.0M |
| May 6, 2026 | -$0.05 | -$0.09 | Miss -91.49% | $105.9M |
| Mar 18, 2026 | $0.00 | -$0.13 | Miss -8740.82% | $173.2M |
| Nov 12, 2025 | -$0.03 | -$0.02 | Beat 34.71% | $114.0M |
| Aug 13, 2025 | -$0.05 | $0.11 | Beat 330.17% | $173.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026